| IEVAX | TEDSX | IEVAX / TEDSX | |
| Total Expense Ratio | 1.12 | 1.95 | 57% |
| Annual Report Gross Expense Ratio | 1.12 | 1.95 | 57% |
| Fund Existence | 31 years | 34 years | - |
| Gain YTD | 8.061 | 6.741 | 120% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 1000 | 200% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 893M | 9.45B | 9% |
| Annual Yield % from dividends | 3.02 | 0.77 | 393% |
| Returns for 1 year | 8.80 | 8.22 | 107% |
| Returns for 3 years | 27.75 | 13.00 | 213% |
| Returns for 5 years | 18.25 | 6.69 | 273% |
| Returns for 10 years | 46.88 | 20.90 | 224% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DBOAX | 25.63 | 0.10 | +0.39% |
| BNY Mellon Balanced Opportunity A | |||
| DRRIX | 17.74 | 0.02 | +0.11% |
| BNY Mellon Global Real Return - I | |||
| VWICX | 19.17 | 0.02 | +0.10% |
| Vanguard International Core Stock Inv | |||
| FIDFX | 37.91 | -0.11 | -0.29% |
| Fidelity Advisor Mid Cap Value Z | |||
| LYFCX | 17.38 | -0.49 | -2.74% |
| AlphaCentric Life Sciences & Hlthcare C | |||